Gunnar Fager

A DOUBLE‐BLIND CROSS‐OVER 12‐MONTH STUDY OF <scp>l</scp>‐THYROXINE TREATMENT OF WOMEN WITH ‘SUBCLINICAL’ HYPOTHYROIDISM

Ernst Nyström, Kenneth Caidahl, Gunnar Fager et al. · Clinical Endocrinology · 1988 · 314 citations

Apolipoprotein(a) and ischaemic heart disease in familial hypercholesterolaemia

Olov Wiklund, S. Olofsson, Gunnar Fager et al. · The Lancet · 1990 · 202 citations

Metabolic Syndrome, Lipid Disorder, Cardiovascular Disease +6

Effect of arterial proteoglycans and glycosaminoglycans on low density lipoprotein oxidation and its uptake by human macrophages and arterial smooth muscle cells.

Eva Hurt‐Camejo, Germán Camejo, Birgitta Rosengren et al. · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · 1992 · 182 citations

Vascular Disease, Lipid Peroxidation, Cellular Physiology +17

Absorption, Distribution, Metabolism, and Excretion of Ximelagatran, an Oral Direct Thrombin Inhibitor, in Rats, Dogs, and Humans

Ulf G. Eriksson, Ulf Bredberg, Kurt‐Jürgen Hoffmann et al. · Drug Metabolism and Disposition · 2003 · 154 citations

Binding of low density lipoproteins by proteoglycans synthesized by proliferating and quiescent human arterial smooth muscle cells

Germán Camejo, Gunnar Fager, Birgitta Rosengren et al. · Journal of Biological Chemistry · 1993 · 142 citations · Full text

Mechanobiology, Low Density Lipoprotein, Glycosylation +14